Buy Crypto Markets Spot FuturesETH Earn Event Centre Rewards Hub

Scribe Therapeutics Inc. (SCTX)

NASDAQ

$29.50

$-0.19

(-0.64%)

Pre-Market

Scribe Therapeutics Inc. (SCTX) Live Price Chart

Last updated: ⁦2026-09-14 09:36:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Scribe Therapeutics Inc. (SCTX) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $29.50, with a market capitalisation of $563.03M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $17.31 to $39.60. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$563.03M
Open	$29.69
Day's High	$39.60
Day's Low	$17.31
Previous Close	$29.74
Volume	8.00
Average Volume	242.75K
P/E Ratio	--
52-Week High	$39.60
52-Week Low	$17.31
Dividend Yield	--
Earnings Date	--

Scribe Therapeutics Inc. (SCTX) Pre-Market Stock Price

Scribe Therapeutics Inc. (SCTX) is trading at $29.50 in pre-market trading as of 2026-09-14 09:07:00, down 0.81% ($0.24) from the previous close of $29.74

Pre-market trading shows how investors are pricing SCTX before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.

Scribe Therapeutics Inc. (SCTX) 7-Day Stock Price Change

Over the past seven days, Scribe Therapeutics Inc. (SCTX) moved from $30.90 to $29.50, representing a decline of 4.53% ($1.40).

The stock traded between $27.61 and $32.41 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.

The average daily volume was 182.65 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

SCTX 52-Week Price Position

Position in Range: 54.7%

52W Low$17.31

52W High$39.60

SCTX is currently trading at $29.50, placing it 54.7% of the way from its 52-week low of $17.31 to its 52-week high of $39.60. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Scribe Therapeutics Inc. (SCTX)?

Scribe Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of in vivo CRISPR-based genetic medicines. Its research and development activities focus on cardiovascular and metabolic diseases, including atherosclerotic cardiovascular disease (ASCVD). The company's product pipeline includes STX-1150, a CRISPR-based product candidate that utilizes its ELXR epigenetic silencing technology.

Scribe Therapeutics Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Exchange	NASDAQ
Company Website	https://www.scribetx.com

How to Buy Scribe Therapeutics Inc. (SCTX) Stock on MEXC

Eligible investors can buy real shares of Scribe Therapeutics Inc. (SCTX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for SCTX and Place Your Order

Open the RealStocks trading page and search for SCTX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Scribe Therapeutics Inc. (SCTX) share price today?

Scribe Therapeutics Inc. (SCTX) is currently trading at $ 29.50, down 0.81% ($0.24) from the previous close of $ 29.74. Intraday prices update in real time during regular trading hours.

2.Is SCTX stock going up or down today?

As of 2026-09-14 09:07:00, SCTX is trading at $ 29.50, down 0.81% ($0.24) from its previous close of $ 29.74. The stock has traded between $ 17.31 and $ 39.60 during today’s regular session. Past price movements do not guarantee future results.

3.What is SCTX pre-market price?

As of 2026-09-14 09:07:00, SCTX is trading at $ 29.50 in pre-market trading, down 0.81% ($0.24) from the previous close of $ 29.74. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is SCTX after-hours price?

As of 2026-09-14 09:07:00, SCTX is trading at $ 29.96 in after-hours trading, up 0.72% ($0.21) from the regular-session close of $ 29.74. After-hours prices may differ from the regular session's opening price due to lower liquidity and wider bid-ask spreads.

5.Is SCTX stock trading now?

SCTX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does SCTX sit relative to its 52-week high and low?

Over the past 52 weeks, SCTX has traded between a low of $ 17.31 and a high of $ 39.60. At $ 29.50, the stock is positioned 54.7% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Scribe Therapeutics Inc. in?

Scribe Therapeutics Inc. (SCTX) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Scribe Therapeutics Inc.'s market capitalisation and where is it listed?

Scribe Therapeutics Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 563.03M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is SCTX valued in terms of P/E ratio and EPS?

SCTX trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Scribe Therapeutics Inc. pay a dividend?

Scribe Therapeutics Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.